Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area valuesWalter J Loos, Felix E de Jongh, Alex Sparreboom, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patientsMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.Journal of Pain and Symptom Management|August 21, 2007
Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diaryWendy H Oldenmenger, Michael A Echteld, Rianne de Wit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responsesJohanna E A Portielje, Cor H J Lamers, Wim H J Kruit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic responseHerman Burger, John A Foekens, Maxime P Look, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecanWalter J Loos, Jaap Verweij, Diederik F S Kehrer, et al.Psychosomatics|January 24, 2008
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipatedMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.Anti-Cancer Drugs|June 19, 2004
Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrationsArthur R Van Gool, Heidi H van Ojik, Wim H J Kruit, et al.Neuropsychobiology|September 18, 2007
Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effectsMarjolein Bannink, Durk Fekkes, Arthur R Van Gool, et al.Amino Acids|October 28, 2008
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapyDurk Fekkes, Arthur R Van Gool, Marjolein Bannink, et al.Pageof 4